Gene · 6783
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy. | Cancer Immunol Res | 2022 | 34911739 | PubTator, text mining | PubMed |
| Luxeptinib disables NLRP3 inflammasome-mediated IL-1β release and pathways required for secretion of inflammatory cytokines IL-6 and TNFα. | Biochem Pharmacol | 2022 | 34843717 | PubTator, text mining | PubMed |
| CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles. | J Cell Commun Signal | 2022 | 34841476 | PubTator, text mining | PubMed |
| Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol's Pharmacological Effects on Type I Endometrial Cancer. | Anticancer Agents Med Chem | 2022 | 34773964 | PubTator, text mining | PubMed |
| CSNK2 in cancer: pathophysiology and translational applications. | Br J Cancer | 2022 | 34773100 | PubTator, text mining | PubMed |
| Suppression of cdc13-2-associated senescence by pif1-m2 requires Ku-mediated telomerase recruitment. | G3 (Bethesda) | 2022 | 34751785 | PubTator, text mining | PubMed |
| Kincore: a web resource for structural classification of protein kinases and their inhibitors. | Nucleic Acids Res | 2022 | 34643709 | PubTator, text mining | PubMed |
| Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC. | Mol Oncol | 2022 | 34605158 | PubTator, text mining | PubMed |
| Multi-omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy. | Epilepsia Open | 2022 | 34486831 | PubTator, text mining | PubMed |
| Maturation and shuttling of the yeast telomerase RNP: assembling something new using recycled parts. | Curr Genet | 2022 | 34476547 | PubTator, text mining | PubMed |
| Insights into the effects of difenoconazole on the livers in male mice at the biochemical and transcriptomic levels. | J Hazard Mater | 2022 | 34425431 | PubTator, text mining | PubMed |
| Drug Interactions Involving 17α-Ethinylestradiol: Considerations Beyond Cytochrome P450 3A Induction and Inhibition. | Clin Pharmacol Ther | 2022 | 34342002 | PubTator, text mining | PubMed |
| Liamocins biosynthesis, its regulation in Aureobasidium spp., and their bioactivities. | Crit Rev Biotechnol | 2022 | 34154468 | PubTator, text mining | PubMed |
| Recent advances in the ontogeny of drug disposition. | Br J Clin Pharmacol | 2022 | 33733546 | PubTator, text mining | PubMed |
| Hi-C Metagenomics in the ICU: Exploring Clinically Relevant Features of Gut Microbiome in Chronically Critically Ill Patients. | Front Microbiol | 2021 | 35185811 | PubTator, text mining | PubMed |
| Prognostic value of microRNA-125a/b family in patients with gastric cancer: a meta-analysis. | Gastroenterol Hepatol Bed Bench | 2021 | 35154597 | PubTator, text mining | PubMed |
| MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing. | Front Mol Biosci | 2021 | 35127818 | PubTator, text mining | PubMed |
| Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database. | Transl Androl Urol | 2021 | 35070817 | PubTator, text mining | PubMed |
| The Environmental Pollutant Bromophenols Interfere With Sulfotransferase That Mediates Endocrine Hormones. | Front Endocrinol (Lausanne) | 2021 | 35069453 | PubTator, text mining | PubMed |
| The role of cancer stromal fibroblasts in mediating the effects of tobacco-induced cancer cell growth. | Cancer Cell Int | 2021 | 34953503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6783/papers?page=20